Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 22705100)

1.

Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.

Yong JH, Beca J, McGowan T, Bremner KE, Warde P, Hoch JS.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):521-31. doi: 10.1016/j.clon.2012.05.004. Epub 2012 Jun 15.

PMID:
22705100
2.

Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.

Hummel S, Simpson EL, Hemingway P, Stevenson MD, Rees A.

Health Technol Assess. 2010 Oct;14(47):1-108, iii-iv. doi: 10.3310/hta14470. Review.

3.

Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.

Yong JH, Beca J, O'Sullivan B, Huang SH, McGowan T, Warde P, Hoch JS.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):532-8. doi: 10.1016/j.clon.2012.05.010. Epub 2012 Jun 26.

PMID:
22739256
4.

A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed.

Carter HE, Martin A, Schofield D, Duchesne G, Haworth A, Hornby C, Sidhom M, Jackson M.

Radiother Oncol. 2014 Aug;112(2):187-93. doi: 10.1016/j.radonc.2014.03.020. Epub 2014 Jun 11.

PMID:
24929702
5.

A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer.

Hummel SR, Stevenson MD, Simpson EL, Staffurth J.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):e159-67. doi: 10.1016/j.clon.2012.09.003. Epub 2012 Oct 3.

PMID:
23040143
6.
7.

Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.

Konski A, Watkins-Bruner D, Feigenberg S, Hanlon A, Kulkarni S, Beck JR, Horwitz EM, Pollack A.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):408-15. Epub 2006 Aug 2.

PMID:
16887291
8.

Cost-effectiveness analysis of SBRT versus IMRT: an emerging initial radiation treatment option for organ-confined prostate cancer.

Hodges JC, Lotan Y, Boike TP, Benton R, Barrier A, Timmerman RD.

Am J Manag Care. 2012 May 1;18(5):e186-93.

9.

Comparison of treatment volumes and techniques in prostate cancer radiation therapy.

Lee CT, Dong L, Ahamad AW, Choi H, Cheung R, Lee AK, Horne DF Jr, Breaux AJ, Kuban DA.

Am J Clin Oncol. 2005 Dec;28(6):618-25.

PMID:
16317275
10.

Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.

Luxton G, Hancock SL, Boyer AL.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):267-84.

PMID:
15093924
11.

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA.

Radiat Oncol. 2014 Feb 4;9:44. doi: 10.1186/1748-717X-9-44.

12.

Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer.

Kohler RE, Sheets NC, Wheeler SB, Nutting C, Hall E, Chera BS.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):683-9. doi: 10.1016/j.ijrobp.2013.08.011.

PMID:
24138916
13.

Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.

Swanson EL, Indelicato DJ, Louis D, Flampouri S, Li Z, Morris CG, Paryani N, Slopsema R.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1549-57. doi: 10.1016/j.ijrobp.2011.10.014. Epub 2012 Jan 21.

PMID:
22270176
14.

Intensity-modulated radiotherapy in the treatment of prostate cancer.

Bauman G, Rumble RB, Chen J, Loblaw A, Warde P; Members of the IMRT Indications Expert Panel.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):461-73. doi: 10.1016/j.clon.2012.05.002. Epub 2012 Jun 4. Review.

PMID:
22673744
15.

Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

Pinkawa M, Piroth MD, Holy R, Djukic V, Klotz J, Krenkel B, Eble MJ.

Strahlenther Onkol. 2011 Aug;187(8):479-84. doi: 10.1007/s00066-011-2249-z. Epub 2011 Jul 25.

PMID:
21789739
16.

Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.

Corletto D, Iori M, Paiusco M, Brait L, Broggi S, Ceresoli G, Iotti C, Calandrino R, Fiorino C.

Radiother Oncol. 2003 Feb;66(2):185-95.

PMID:
12648791
17.

Protons in head-and-neck cancer: bridging the gap of evidence.

Ramaekers BL, Grutters JP, Pijls-Johannesma M, Lambin P, Joore MA, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1282-8. doi: 10.1016/j.ijrobp.2012.11.006. Epub 2012 Dec 27.

18.

The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer.

Horwitz EM, Hanlon AL, Pinover WH, Hanks GE.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1219-25.

PMID:
10613316
19.

A cost-outcome analysis of Image-Guided Patient Repositioning in the radiation treatment of cancer of the prostate.

Ploquin N, Dunscombe P.

Radiother Oncol. 2009 Oct;93(1):25-31. doi: 10.1016/j.radonc.2009.03.023. Epub 2009 May 4.

PMID:
19409635
20.

Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?

Konski A, Speier W, Hanlon A, Beck JR, Pollack A.

J Clin Oncol. 2007 Aug 20;25(24):3603-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk